Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Momenta Pharmaceuticals (MNTA) gains 5.7% AH after announcing it has entered into a...

  • Thursday, December 22, 2011, 4:32 PM ET
    Momenta Pharmaceuticals (MNTA) gains 5.7% AH after announcing it has entered into a collaboration with Baxter (BAX) to develop a class of drugs called biosimilars. As part of the deal, Baxter will make a $33M up-front payment to Momenta related to the development of six drug compounds, and "may make additional payments over the next several years."
Track new comments on this story

This news story has 1 comment:

  •  
    I have owned MNTA for a couple of years now, and use it mostly to sell Call Options against it which have served me well. What do you do?
    28 Dec 2011, 10:02 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »